Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Artelo Biosciences Inc. (ARTL)

  • Technical Exchange News
  • April 30, 2025, 22:43 UTC
  • 38
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

ALX Oncology Inc (ALXO)

  • Technical Exchange News
  • April 30, 2025, 22:43 UTC
  • 41
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Vor Biopharma Inc (VOR)

  • Technical Exchange News
  • April 30, 2025, 01:43 UTC
  • 55
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Quoin Pharmaceuticals Ltd DRC (QNRX)

  • Technical Exchange News
  • April 30, 2025, 01:42 UTC
  • 53
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

P3 Health Partners Inc (PIII)

  • Technical Exchange News
  • April 30, 2025, 01:42 UTC
  • 51
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Celularity Inc. (CELU)

  • Technical Exchange News
  • April 30, 2025, 01:42 UTC
  • 54
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Delinquent. New value: Deficient and Delinquent.

Comment Full text

Celularity Inc. (CELUW)

  • Technical Exchange News
  • April 30, 2025, 01:42 UTC
  • 52
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Delinquent. New value: Deficient and Delinquent.

Comment Full text

Vor Biopharma Inc (VOR)

  • Technical Exchange News
  • April 29, 2025, 19:20 UTC
  • 50
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Quoin Pharmaceuticals Ltd DRC (QNRX)

  • Technical Exchange News
  • April 29, 2025, 19:20 UTC
  • 49
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

P3 Health Partners Inc (PIII)

  • Technical Exchange News
  • April 29, 2025, 19:20 UTC
  • 48
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 189
  • 190
  • 191
  • 192
  • 193
  • Next

Search

News categories

  • Technical Exchange News(10877)
  • Event(2261)
  • SEC News(189350)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124575)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin